Featured Research

from universities, journals, and other organizations

Frequent Urination Protects Against Bladder Cancer, Study Finds

Date:
October 31, 2008
Source:
Plataforma SINC
Summary:
A new study has analyzed the effect of urinary frequency on the risk of bladder cancer. The research shows a direct association between the number of times people get up at night to urinate and protection against bladder cancer.

A new study has analyzed the effect of urinary frequency on the risk of bladder cancer. The research, which is published in the latest number of the International Journal of Cancer, shows a direct association between the number of times people get up at night to urinate and protection against bladder cancer.

Night-time is usually the period during which there is the longest time interval between urination. For this reason the “length of time carcinogenic agents, such as those from tobacco for example, are present in the urine, constitutes an important factor towards the likelihood of developing bladder cancer”, explains Juan Alguacil to SINC. Juan Alguacil is a researcher from the University of Huelva and one of the authors of the study, which has appeared recently in the International Journal of Cancer.

The research group, made up of Spanish and North American scientists, analysed the urinary frequency in 884 recently diagnosed bladder cancer cases and in 996 non-cancer ‘control patients’, from five regions in Spain. The patients, aged between 21 and 80 years, came from 18 hospitals in Vallιs, Barcelona, Asturias, Alicante and Tenerife.

Although the best advice is to avoid exposure to carcinogenic agents (e.g. to stop smoking and to avoid direct contact with chemical products or pollution particles), the risk of bladder cancer could be reduced by increasing urinary frequency and drinking water.

The results of the analysis indicate that those people who usually get up at night at least twice to pass urine reduced their risk of suffering from bladder cancer by 40-59%. This “protective effect” was found in both men and women and did not relate to the consumption of tobacco or the quantity of water they drank.

This is an exhaustive international study undertaken to date about the effect of urinary frequency in bladder cancer. The authors underline that “it would be necessary to transport this discovery from the laboratory to the hospital in order to achieve the prevention of almost 357,000 new cases of bladder cancer that are diagnosed every year throughout the world, and the 145,000 deaths that are caused by this cancer.

The data put forward last July in the latest session of the Spanish National Congress of Urology indicate that in Spain more than 15,000 new cases of bladder cancer are diagnosed every year. The incidence of this tumour, one of the highest in the world, is rising mainly due to a greater life expectancy for the population and to the increasing incidence amongst women.

According to the experts, to an extraordinary degree, the consumption of tobacco is leading to an increase of the incidence of this disease among women, which until now has been infrequent. In fact, it is estimated that in the near future the incidence of bladder cancer will be equal in both sexes, owing to the increase in the number of women who smoke. According to the conclusions of the congress, between 50 and 70% of smokers will end up developing a tumour of this type, the main warning sign of which is the appearance of blood in the urine.


Story Source:

The above story is based on materials provided by Plataforma SINC. Note: Materials may be edited for content and length.


Journal Reference:

  1. Silverman et al. Does increased urination frequency protect against bladder cancer? International Journal of Cancer, 2008; 123 (7): 1644 DOI: 10.1002/ijc.23572

Cite This Page:

Plataforma SINC. "Frequent Urination Protects Against Bladder Cancer, Study Finds." ScienceDaily. ScienceDaily, 31 October 2008. <www.sciencedaily.com/releases/2008/10/081030194232.htm>.
Plataforma SINC. (2008, October 31). Frequent Urination Protects Against Bladder Cancer, Study Finds. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2008/10/081030194232.htm
Plataforma SINC. "Frequent Urination Protects Against Bladder Cancer, Study Finds." ScienceDaily. www.sciencedaily.com/releases/2008/10/081030194232.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins